Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Oulu
AddAla-Kokko, L.
AddAla-Kokko, T(ero)
AddAla-Korpela, M(ika)
AddAlahuhta, S.
AddAlén, M(arkku)
AddAntikainen, R.
AddAnttonen, V(uokko)
AddBiancari, F(austo)
AddBloigu, R(isto)
AddEskelinen, S.
AddFlinkkilä, T(apio)
AddHakkola, J.
AddHallman, M.
AddHartikainen, A(nna)-L(iisa)
AddHausen, H.
AddHautala, N(ina)
AddHautala, T(imo)
AddHeape, A.
AddHerzig, K(arl)-H(einz)
AddHillbom, M.
AddHiltunen, J.K.
AddHörkko, S.
AddHuikuri, H(eikki)
AddHukkanen J(anne)
AddIgnatius, J.
AddIsohanni, M.
AddJaakkola, J.
AddJaakkola, M(aritta) S.
AddJaakola, V-P.
AddJämsä, T(imo)
AddJanhonen, S.
AddJartti, T(uomas)
AddJärvelin, M(arjo)-R(iitta)
AddJokelainen, J(ari)
AddJuffer, A(ndré) H.
AddJunttila, J(uhani)
AddJuvonen, T.
AddKaarteenaho, R(iitta)
AddKajantie, E(ero)*(THL/OY)
AddKarppinen (Koivunen), P(eppi)
AddKarppinen, J(aro)
AddKarttunen, T.J.
AddKeinänen-Kiukaanniemi, S(irkka)
AddKerkelä, R(isto)
AddKesäniemi, Y(rjö) A(ntero)
AddKettunen, J(ohannes)
AddKietzmann, T(homas).
AddKivirikko, K.I.
AddKnuuttila, M.
AddKoivukangas, J.
AddKursula, P(etri)
AddKyngäs, H.
AddLarivaara, P.
AddLarmas, M.
AddLehenkari, P(etri)
AddLehtiö, L(ari)
AddLeppilahti, J.
AddLuukinen, H.
AddMainio A
AddMajamaa, K.
AddMäki, P(irjo)
AddMäkikallio, T(imo) H.
AddMännikkö, M(inna)
AddManninen, A(ki).
AddMartikainen, H(annu)
AddMiettunen, J(ouko)
AddMyllyharju, J(ohanna)
AddMyllylä, R.
AddMyllylä, V.
AddNäyhä, S(imo)
AddNeubauer, P.
AddNieminen, M(iika) T.
AddNieminen, P(entti)
AddNiinimäki, J(aakko)
AddOhukainen, P(auli)
AddOikarinen, A.
AddOikarinen, K.
AddPelkonen, O(lavi)
AddPetäjä-Repo, U.E.
AddPihlajaniemi, T(aina)
AddPirttiniemi, P(ertti)
AddPuistola, U(lla)
AddRajaniemi, H.J.
AddRäsänen, P.
AddRaustia, A.
AddRemes, A(nne)
AddRisteli, J.
AddRistiniemi, J.
AddRuddock, L.W.
AddRuokonen, A.
AddRyynänen, M.
AddSaarakkala, S.
AddSaari, A.
AddSalo, T(uula)
AddSándor, G(eorge) K.
AddSavolainen, E-R.
AddSavolainen, M.J.
AddSavolainen, O.
AddSillanpää, M(ikko).
AddSoininen, R.
AddSorri, M.
AddTaanila, A.
AddTapiainen, T(erhi)
AddTervonen, O(smo)
AddTimonen, M(arkku)
AddTurpeenniemi-Hujanen, T.
AddTuukkanen, J(uha)
AddTuulonen, A.
AddUhari, M.
AddUkkola, O(lavi)
AddUusimaa, J.
AddVainio, O.
AddVainio, S.
AddVäyrynen, J(uha) P.
AddVeijola, J(uha)
AddVeijola, R(iitta)
AddVirokannas, H.
AddVoipio, H(anna)-M(arja)
AddVuolteenaho, O.
AddWeckström, M.
AddWei, GH.
AddWierenga, R.K.
AddWinqvist, R(obert)
AddYlänne, J.
AddYlitalo, K(ari)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Thujone and thujone-containing herbal medicinal and botanical products: toxicological assessment.Pelkonen, O(lavi)3280 dayssaveRefWorks
The inhibition of major human hepatic cytochrome P450 enzymes by 18 pesticides: comparison of the N-in-one and single substrate approaches.Pelkonen, O(lavi)3470 dayssaveRefWorks
Review of current and "omics" methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms.Pelkonen, O(lavi)3548 dayssaveRefWorks
Omics and its potential impact on R&D and regulation of complex herbal products.Pelkonen, O(lavi)3578 dayssaveRefWorks
Characterization of human cytochrome P450 induction by pesticides.Pelkonen, O(lavi)3578 dayssaveRefWorks
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*.Pelkonen, O(lavi)3582 dayssaveRefWorks
Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.Pelkonen, O(lavi)3609 dayssaveRefWorks
Hepatocytes: The powerhouse of biotransformation.Pelkonen, O(lavi)3651 dayssaveRefWorks
In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions.Pelkonen, O(lavi)3792 dayssaveRefWorks
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Pelkonen, O(lavi)3862 dayssaveRefWorks
Metabolism of Ophthalmic Timolol: New Aspects of an Old Drug.Pelkonen, O(lavi)3916 dayssaveRefWorks
Metabolism of ?-thujone in human hepatic preparations in vitro.Pelkonen, O(lavi)4026 dayssaveRefWorks
Placental transfer and DNA-binding of benzo(a)pyrene in human placental perfusion.Pelkonen, O(lavi)4215 dayssaveRefWorks
Metabolism of Carbosulfan II. Human Interindividual Variability in its In Vitro Hepatic Biotransformation and the Identification of the Cytochrome P450 Isoforms Involved.Pelkonen, O(lavi)4267 dayssaveRefWorks
Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail.Pelkonen, O(lavi)4279 dayssaveRefWorks
An evaluation of the cytochrome P450 inhibition potential of selected pesticides in human hepatic microsomes.Pelkonen, O(lavi)4293 dayssaveRefWorks
[Why does acetylsalicylic acid have so many effects and applications?]Pelkonen, O(lavi)4324 dayssaveRefWorks
Effects of Selective Serotonin Reuptake Inhibitors on Timolol Metabolism in Human Liver Microsomes and Cryo-Preserved Hepatocytes.Pelkonen, O(lavi)4394 dayssaveRefWorks
Comparison of metabolic stability and metabolite identification of 55 ECVAM/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis.Pelkonen, O(lavi)4398 dayssaveRefWorks
Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models.Pelkonen, O(lavi)4546 dayssaveRefWorks
Metabolism of Carbosulfan. I. Species Differences in the In Vitro Biotransformation by Mammalian Hepatic Microsomes Including Human.Pelkonen, O(lavi)4548 dayssaveRefWorks
Functional Expression, Inhibition and Induction of CYP Enzymes in HepaRG cells.Pelkonen, O(lavi)4625 dayssaveRefWorks
Expression of cytochrome P450 (CYP) enzymes in human non-pigmented ciliary epithelial cells; induction of CYP1B1 expression by TCDD.Pelkonen, O(lavi)4628 dayssaveRefWorks
Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.Pelkonen, O(lavi)4665 dayssaveRefWorks
Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.Pelkonen, O(lavi)4737 dayssaveRefWorks
Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2mum particle size column.Pelkonen, O(lavi)4755 dayssaveRefWorks
Schizophrenia and sudden cardiac death-A review.Pelkonen, O(lavi)4838 dayssaveRefWorks
Local Kinetics and Dynamics of Xenobiotics.Pelkonen, O(lavi)4860 dayssaveRefWorks
Cytochromes P450, induction and cholesterol-what are the connections?Pelkonen, O(lavi)4881 dayssaveRefWorks
Inhibition and induction of human cytochrome P450 enzymes: current status.Pelkonen, O(lavi)4887 dayssaveRefWorks
Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.Pelkonen, O(lavi)4891 dayssaveRefWorks
Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.Pelkonen, O(lavi)4999 dayssaveRefWorks
In vitro-in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations.Pelkonen, O(lavi)5142 dayssaveRefWorks
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.Pelkonen, O(lavi)5148 dayssaveRefWorks
Risk of retinal microembolism after off-pump and on-pump coronary artery bypass surgery.Pelkonen, O(lavi)5153 dayssaveRefWorks
Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro.Pelkonen, O(lavi)5154 dayssaveRefWorks
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme-an in silico approach.Pelkonen, O(lavi)5163 dayssaveRefWorks
In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies.Pelkonen, O(lavi)5280 dayssaveRefWorks
Aryl Hydrocarbon Receptor Nuclear Translocator and Upstream Stimulatory Factor Regulate Cytochrome P450 2a5 Transcription through a Common E-box Site.Pelkonen, O(lavi)5325 dayssaveRefWorks
Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.Pelkonen, O(lavi)5342 dayssaveRefWorks
Metabolism and pharmacokinetics in children and the elderly.Pelkonen, O(lavi)5343 dayssaveRefWorks
Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites.Pelkonen, O(lavi)5381 dayssaveRefWorks
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.Pelkonen, O(lavi)5387 dayssaveRefWorks
[In Process Citation]Pelkonen, O(lavi)5426 dayssaveRefWorks
The Functional Role of CYP2B6 in Human Drug Metabolism: Substrates and Inhibitors In Vitro, In Vivo and In Silico.Pelkonen, O(lavi)5506 dayssaveRefWorks
In vitro screening of drug metabolism during drug development: can we trust the predictions?Pelkonen, O(lavi)5554 dayssaveRefWorks
Metabolic and efflux properties of caco-2 cells stably transfected with nuclear receptors.Pelkonen, O(lavi)5564 dayssaveRefWorks
Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver.Pelkonen, O(lavi)5585 dayssaveRefWorks
Cytochrome P450 (CYP) inhibition screening: Comparison of three tests.Pelkonen, O(lavi)5592 dayssaveRefWorks
 XML / RSS feed
 « prev   page 2    next »